Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-04-003850
Filing Date
2004-02-12
Accepted
2004-02-12 14:34:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a04-2312_4sc13g.htm SC 13G 60454
  Complete submission text file 0001104659-04-003850.txt   62362
Mailing Address 225 SOUTH LAKE AVE SUITE 400 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVE STE 400 PASADENA CA 91101-3005 8183049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

EIN.: 953868081

Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 04590189
SIC: 2834 Pharmaceutical Preparations